News about Global Pharma

Zuellig Pharma Signs Exclusive Distribution Deal with Regeneron to Launch Libtayo

Regeneron is a biotechnology company that invents, develops and commercialises life-transforming medicines for people with serious diseases.

Global Pharma | 28/08/2024 | By Aishwarya |  564

VION Biosciences Acquires Echelon Biosciences

This acquisition serves as the second investment under VION Biosciences, Iron Path Capital’s roll-up platform in the life science sector led by life science industry veteran, Mark Thornton.

Global Pharma | 27/08/2024 | By Aishwarya |  833

Lupin Secures Health Canada Approval for Biosimilar Pegfilgrastim

Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim.

Global Pharma | 26/08/2024 | By Aishwarya |  535

ST Pharm Extends Partnership with Quantoom Biosciences to Advance RNA Manufacturing

By combining their respective strengths and expertise, ST Pharm and Quantoom aim to expand their global reach and provide comprehensive solutions to the RNA manufacturing market.

Global Pharma | 23/08/2024 | By Aishwarya |  741

PhotonPharma Receives USD 2.5 Million in Seed Funding Round

This vital funding will support the Phase I clinical trial of Innocell, an innovative therapy for the treatment of advanced ovarian cancer.

Global Pharma | 22/08/2024 | By Aishwarya |  738

BioMarin Strengthens its Leadership with New Appointments

At BioMarin, he will assume responsibility for the company's R&D organization, including discovery research, preclinical, translational and clinical programs, as well as global regulatory and medical affairs.

Global Pharma | 22/08/2024 | By Aishwarya |  836

Qubit Pharmaceuticals Receives Nomination for Best Start-Up 2024 Award

Qubit Pharmaceuticals, a deeptech company specializing in the discovery of new drug candidates through simulation and molecular modeling accelerated by hybrid HPC and quantum computing, has been nominated for the Prix Galien USA 'Best Startup Award'.

Global Pharma | 22/08/2024 | By Aishwarya |  644

Pathalys Pharma Bags USD 105 Million in Series B Financing

The funds raised via this financing will be utilized to finalize the two ongoing upacicalcet clinical trials, execution of the NDA filing process with the US Food and Drug Administration (FDA), and acceleration of preapproval commercialization preparations.

Global Pharma | 21/08/2024 | By Aishwarya |  800

Amneal Secures FDA Approval for Propofol Injectable Emulsion Single Dose Vials

Propofol is an intravenous drug commonly used in hospitals for the induction and maintenance of anesthesia and sedation.

Global Pharma | 21/08/2024 | By Aishwarya |  683

LMI and PharmaLogic to Supply Neuraceq in Denver

Neuraceq is an FDA-approved imaging agent for the detection of beta-amyloid plaques in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline.

Global Pharma | 21/08/2024 | By Aishwarya |  414